Investor Deadline Looms: FS KKR and ADMA Biologics Face Critical Lawsuit Milestone

New York, Thursday, 18 June 2026.
Two major companies, FS KKR Capital and ADMA Biologics, are at the center of investor lawsuits with a crucial deadline on July 6, 2026. Shareholders who suffered financial losses are urged to step forward as lead plaintiffs, a role that could shape the legal battle ahead. These lawsuits underscore growing concerns over corporate governance and financial disclosures, with potential repercussions for market stability and investor trust. The outcome could lead to significant financial penalties, impacting both companies’ futures and shareholder relations.